Anticoagulation policy during use of aprotinin in cardiopulmonary bypass.
van Oeveren
W
W
van Oeveren
B
B
Wildevuur
C R
CR
D007611:Aprotinin / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D002315:Cardiopulmonary Bypass; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D014914:Whole Blood Coagulation Time
D006493:Heparin; D007611:Aprotinin